WO2021036384A1 - Method for purifying vitamin d3 - Google Patents

Method for purifying vitamin d3 Download PDF

Info

Publication number
WO2021036384A1
WO2021036384A1 PCT/CN2020/093960 CN2020093960W WO2021036384A1 WO 2021036384 A1 WO2021036384 A1 WO 2021036384A1 CN 2020093960 W CN2020093960 W CN 2020093960W WO 2021036384 A1 WO2021036384 A1 WO 2021036384A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
purifying
lipase
ester
column
Prior art date
Application number
PCT/CN2020/093960
Other languages
French (fr)
Chinese (zh)
Inventor
蔡育森
余曦
何剑洋
王志强
许德兴
魏高宁
Original Assignee
厦门金达威维生素有限公司
厦门金达威集团股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 厦门金达威维生素有限公司, 厦门金达威集团股份有限公司 filed Critical 厦门金达威维生素有限公司
Publication of WO2021036384A1 publication Critical patent/WO2021036384A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group

Definitions

  • the present invention relates to the field of vitamins, particularly to a method for the purification of vitamin D 3.
  • Vitamin D 3 also known as cholecalciferol, has the physiological functions of promoting intestinal calcium absorption, regulating calcium and phosphorus metabolism, and inducing bone calcium and phosphorus deposition. It can promote bone growth and prevent rickets. Large doses are also used for skin tuberculosis. , Skin and mucous membranes of various types of lupus erythematosus, etc.
  • Vitamin D 3 synthesized by photochemical reaction contains tachysterol, photosterol and residual raw material 7-dehydrocholesterol produced by side reactions. Generally, only 20-30 million IU/g of vitamin D 3 can be obtained. These by-products are similar in structure. Similar in nature, it is difficult to further separate and purify.
  • vitamin D 3 purification methods mainly include chemical methods and column chromatography, and there is also a supercritical CO 2 column separation method.
  • the chemical method such as US3157678A, is based on the principle that the illuminated product is made into the corresponding ester, and the difference in solubility in the solvent caused by the difference in the structure of the substance after esterification is used to separate impurities through multiple crystallizations, and then saponified into vitamin D 3 , and then Further crystallization and purification to obtain food-grade vitamin D 3 , the esterification reactant is mainly various acid chlorides.
  • the esterification raw materials such as benzoyl chloride or butyryl chloride are highly toxic and produce more difficult-to-treat waste water and waste residue.
  • the chemical synthesis process is relatively violent, and the yield is also low.
  • the method described in US3157678A is the highest yield of the chemical method recorded in the literature, and the yield of the vitamin D 3 butyl ester crystallization step is 72%.
  • Column chromatography such as US3367950A, requires separation by a chromatographic column, eluting with a large amount of solvent to obtain the main section, and then concentrating and replacing the solvent for crystallization to obtain high-unit vitamin D 3 .
  • Supercritical CO 2 column separation method for example, the supercritical method mentioned in CN1240209A is to use supercritical or liquid carbon dioxide through a chromatographic column, select a modified solvent as the mobile phase, and a modified silica gel as a stationary phase for separation.
  • the equipment pressure is 7.0 ⁇ 15.0MPa.
  • the supercritical column separation method requires the use of high-pressure equipment above 7MPa, the equipment safety requirements are high, and the more expensive modified silica gel is required, the industrialization cost is high, and it is difficult to industrialize the application.
  • the purpose of the present invention is to provide a method for purifying vitamin D3 with high yield, low cost, and environmental friendliness.
  • the present invention provides a method for purifying vitamin D3, which is characterized in that it comprises the following steps:
  • the saponification reaction is carried out through the lipase column B to obtain a saponification liquid; the saponification liquid is extracted with water, and the separated organic acid enters the water layer, and the organic layer is heavy Return to the lipase column B to saponify and hydrolyze the remaining vitamin D 3 ester again, and repeat the cycle of saponification-hydrolysis step 2 to 5 times until the residual vitamin D 3 ester in the organic phase is less than 1wt%, then stop the circulation;
  • the crystallization mother liquor is used as the substrate of step S1 after being concentrated and thermally isomerized.
  • the content of the crude vitamin D 3 in the step S1 is 1500-3500 IU/g;
  • the weight-volume ratio of the substrate to the non-aqueous phase solvent in the S1 step is 1 g: (5-30) ml, preferably 1 g: 8 ml.
  • the non-aqueous solvent is each independently an alkane, a halogenated hydrocarbon or an aromatic hydrocarbon; preferably, the alkane is selected from n-hexane, pentane, heptane, At least one of cyclohexane and petroleum ether.
  • the molar ratio of the substrate to the weak organic acid is 1:(1.0-10); preferably, the molar ratio of the substrate to the weak organic acid is 1:1.1;
  • the weak organic acid is butyric acid, valeric acid or lauric acid.
  • the acid anhydride is n-butyric anhydride, succinic anhydride or valeric anhydride;
  • the molar ratio of the substrate to the acid anhydride is 1:(0.5-5); preferably, the molar ratio of the substrate to the acid anhydride is 1:0.55;
  • the temperature of the esterification reaction is 20-50°C, preferably 35°C;
  • the residence time of the material in the column when passing through the lipase column A is 0.5-5 hours, preferably, 1 hour.
  • the extractant is water or aqueous methanol; preferably, the volume content of methanol in the aqueous methanol is 0-98%, and more preferably, the volume content of methanol in the aqueous methanol is 95%;
  • the feed volume ratio of the extractant to the esterification liquid containing vitamin D 3 ester is (0.2 ⁇ 3):1; preferably, the ratio of the extractant to the esterification liquid containing vitamin D 3 ester The feed volume ratio is 0.8:1.
  • the extraction operations in the S2 step and the S4 step are performed in an extraction tower.
  • the crystallization solvent is a ketone or alcohol solvent; preferably, the crystallization solvent is acetone;
  • the crystallization temperature is -5 to -30°C, preferably, the crystallization temperature is -20°C;
  • the ratio of the concentrated vitamin D 3 ester to the crystallization solvent is 1 g: (0.7-5) ml, preferably 1 g: 1 ml.
  • the mass-volume ratio of the vitamin D 3 ester crystal to the non-aqueous solvent is 1 g: (2-30) ml, preferably 1 g: 5 ml;
  • the temperature of the saponification reaction is 20-50°C, preferably 35°C.
  • the solvent of the crystallization is methyl formate or ethyl acetate, optionally, the temperature of the crystallization is 0-10°C, and the temperature is kept for more than 3 hours;
  • the mass-volume ratio of the concentrate obtained by concentrating the organic layer to the crystallization solvent is 1 g: (4-20) ml, preferably 1 g: 6 ml.
  • the lipase in the lipase column A and the lipase column B is an immobilized Candida antarctica lipase B, preferably, each independently is Novozymes 435 immobilized lipase, or Candida Antarctica lipase B treated by the immobilization method disclosed in CN105462952A;
  • the mass ratio of the substrate to the lipase in the lipase column A is 1:(0.2-30), preferably 1:(0.5-2);
  • the mass ratio of the vitamin D 3 ester crystal to the lipase in the lipase column B is 1:(0.2-30), preferably 1:(0.5-2).
  • the substrate material that can be processed in the present invention can be selected in the range of 1500-3500 IU/g. If the content is too low, the effect of esterification and crystallization is poor, and the enzyme activity is likely to decrease quickly, which affects the number of times of lipase application. If the content is too high, esterification may not be required, and it can be purified directly by crystallization.
  • the present invention improves on the problems of the current chemical synthesis method with relatively low industrialization cost, innovatively adopts the enzyme acylation method to carry out the vitamin D 3 esterification reaction, and then obtains the higher purity vitamin D 3 ester through crystallization and purification, and then Utilizing the reversibility of the enzyme acylation reaction, the vitamin D 3 ester crystal is saponified into vitamin D 3 by enzyme, and finally high unit vitamin D 3 is obtained by crystallization.
  • the invention uses enzymatic method for esterification and saponification, no more toxic raw materials, enzymes can be reused, some raw materials can be recovered, recycled, no solid waste is discharged, conform to the concept of green chemistry, and the enzyme acylation reaction is more gentle , The yield is improved compared with chemical method, and the cost of industrial application is lower.
  • the crystallization yield of vitamin D 3 in the whole process is 50-75.3%, plus the vitamin D 3 in each crystallization mother liquor, the recovery rate of pure vitamin D 3 is 90-97%, that is, the loss of vitamin D 3 in the whole process is 3-10%.
  • the lipase column A and lipase column B are stainless steel or other solvent-resistant material pipe processing cylindrical columns, the shape is shown in Figure 1 but the size is not limited to the drawings, filter paper and defatted cotton are placed at the inlet and outlet to prevent enzymes from being solution
  • the lipase used is immobilized Candida antarctica lipase B, for example, it can be Novozymes 435 immobilized lipase (Novozym R 435), or the Antarctic pseudolipase treated with the immobilization method disclosed in CN105462952A Silk Lipase B. Lipase is applied more than 40 times.
  • the vitamin D 3 crystal detection is based on the 2015 edition of the "Chinese Pharmacopoeia” method to detect specific rotation and absorption coefficient, and the product content is determined based on the “Chinese Pharmacopoeia” general rule 0722 Vitamin D determination method.
  • the present invention uses lipase catalysts for esterification of vitamin D 3, vitamin D 3 or a weak organic acid with an excess of the raw material mixed acid anhydride, an esterification reaction using a lipase in a non-aqueous solvent.
  • the invention uses an extraction tower to extract and remove excess acid from the reaction. After separation, the excess acid can continue to be used for esterification.
  • the invention utilizes the reversibility of the enzyme esterification reaction, uses lipase in the non-aqueous phase solvent to saponify and hydrolyze vitamin D 3 ester, and combines the extraction tower to extract the acid produced by the hydrolysis, and the organic phase circulates through the lipase column to promote the reversible reaction Proceed in the direction of hydrolysis, and finally the hydrolysis rate will reach 99% or more. After separation, the extracted organic acid can be applied to the esterification reaction to achieve recycling utilization.
  • the present invention creatively adopts the lipase method instead of the original chemical method to esterify the raw material vitamin D 3 , avoiding the use of highly toxic and corrosive benzoyl chloride, butyryl chloride and other raw materials.
  • the reaction adopts lipase esterification and saponification, the process is milder than the chemical method, and the yield is obviously improved. Only the esterification and crystallization step has increased by more than 8% compared with the highest 72% in the chemical method.
  • the acid in the water layer of the reaction extraction can be separated and recycled. Compared with the chemical method, there are no difficult-to-treat waste residues and more harmful waste water discharge. Lipase can be recycled many times, which meets the needs of green and environmental protection new industries.
  • the unit of the vitamin D 3 crystal product produced by the present invention exceeds 39 million IU/g, and the detection index meets the requirements of the Chinese Pharmacopoeia.
  • the present invention compared with the chemical method with the lowest industrialization cost, the present invention has higher yield, no high-toxic raw materials, and most of the raw materials can be recycled, avoiding the discharge of waste residues and difficult-to-treat wastewater, and is a greener and more environmentally friendly method. , A lower cost and more economical method for purification of vitamin D 3.
  • Fig. 1 is a schematic diagram of the structure of a lipase column A and a lipase column B according to a specific embodiment of the present invention.
  • Fig. 2 is a schematic flowchart of a specific embodiment of the present invention.
  • the extraction tower becomes the organic phase, which enters and exits from the top, and the water phase enters and exits from the bottom.
  • Vitamin D 3 ester 12.79g was dissolved in 64ml n-hexane and passed through a DN10 ⁇ 500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature was 35°C. After the column was passed, the pump was pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C. After the column is passed, the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester is less than 1wt%, stop passing the column.
  • Vitamin D 3 was dissolved in 69ml of ethyl acetate, filtered through a clean filter, and then slowly cooled and crystallized. After cooling to 5°C, the temperature was kept for 3 hours, filtered, washed with cold ethyl acetate, dried and crystallized to obtain 9.61g of vitamins. D 3 crystal product, unit 39.95 million IU/g, specific rotation +110°, absorption coefficient 471.
  • Vitamin D 3 ester 12.50g is dissolved in 63ml n-hexane and passed through a DN10 ⁇ 500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature is 35°C.
  • the pump is pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C.
  • the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester ⁇ wt 1%, stop passing the column, extract the remaining solution to obtain the organic phase.
  • Vitamin D 3 was dissolved by adding 68ml ethyl acetate, filtered through a clean filter, and then slowly cooled to crystallize. After cooling to 5°C, keep it for 3 hours, filter, wash with cold ethyl acetate, dry and crystallize to obtain 9.48g vitamins D 3 crystal product, unit 39.42 million IU/g, specific rotation +111°, absorption coefficient 473.
  • 12.8g vitamin D 3 ester is dissolved in 64ml n-hexane and passed through the DN10 ⁇ 500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min.
  • the column temperature is 35°C.
  • the pump is pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C.
  • the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester is ⁇ wt 1%, stop passing the column.
  • Vitamin D 3 was dissolved in 69ml of ethyl acetate, filtered through a clean filter, and then slowly cooled and crystallized. After cooling to 5°C, the temperature was kept for 3 hours, filtered, washed with cold ethyl acetate, dried and crystallized to obtain 9.62g vitamins D 3 crystal product, unit 39.7 million IU/g, specific rotation +111°, absorption coefficient 477.
  • Vitamin D 3 ester 12.51g was dissolved in 63ml n-hexane and passed through a DN10 ⁇ 500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature was 35°C.
  • the pump was pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C.
  • the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester ⁇ wt 1%, stop passing the column, extract the remaining solution to obtain the organic phase.
  • Vitamin D 3 was dissolved by adding 68ml ethyl acetate. After filtering through a clean filter, it began to slowly cool down and crystallize. After cooling to 5°C, keep it for 3 hours, filter, wash with cold ethyl acetate, dry and crystallize to obtain 9.23g vitamins D 3 crystal product, unit 39.35 million IU/g, specific rotation +110°, absorption coefficient 474.
  • the coefficient is 480.
  • the total yield of crystallization is 73.3%, and the total recovery of vitamin D 3 is 93.9%.
  • the butyric acid used for esterification was changed to 5.84g (0.057mol) of valeric acid, and the rest was the same as in Example 1.
  • the esterification yielded 12.03g of 98.8% vitamin D 3 amyl ester, and finally 8.34g of vitamin D 3 crystals, with a unit of 39.62 million IU/ g, specific rotation +108°, absorption coefficient 469.
  • the total yield of crystallization is 64.8%, and the total recovery of vitamin D 3 is 91.9%.
  • the column temperature was changed to 45°C, and the rest was the same as in Example 1.
  • the total yield of crystallization is 71.3%, and the total recovery of vitamin D 3 is 91.5%.
  • the dosage of lipase was changed to 10g, and the rest was the same as in Example 1.
  • the esterification conversion rate was 98.5%, and 12.36g of 99.1% vitamin D 3 butyl ester was obtained; after the saponification and hydrolysis step was cycled 4 times, the test was qualified and finally 9.30g of vitamin D 3 crystal was obtained.
  • the unit is 39.79 million IU/g, the specific rotation is +110°, and the absorption coefficient is 483.
  • the total yield of crystallization is 72.5%, and the total recovery of vitamin D 3 is 93.48%.
  • the dosage of lipase was changed to 10g, and the rest was the same as in Example 3.
  • the esterification conversion rate was 98.8% compared with Example 1, and 12.61g of 99.2% vitamin D 3 butyl ester was obtained.
  • the saponification and hydrolysis step was repeated 4 times, the test was qualified and finally vitamin D 3 was obtained.
  • the crystal is 9.51g, the unit is 39.8 million IU/g, the specific rotation is +109°, and the absorption coefficient is 479.
  • the total yield of crystallization is 74.2%, and the total recovery of vitamin D 3 is 95.19%.
  • lipase column A and lipase column B are DN10 ⁇ 500 columns processed with DN10 stainless steel pipes. Filter paper and cotton are placed at the entrance and exit of the column to prevent enzymes from being carried out.
  • the enzyme used is Novozymes 435 lipase and the enzyme activity is 10000 U/g.
  • the enzyme application experiment was performed 40 times in the scheme of Example 1, and the enzyme still had a high efficiency.
  • Lipase column A detected enzyme activity 7230 U/g
  • lipase column B detected enzyme activity 8243 U/g.
  • the water-washing extraction tower is constructed by laboratory glass tower section and wire mesh packing, and the other steps of filtration and concentration are all commonly used instruments in the laboratory.

Abstract

Disclosed is a method for purifying vitamin D3, the method involving: mixing crude vitamin D3 as a substrate with a weak organic acid or anhydride in a non-aqueous solvent, subjecting same to esterification with lipase column A and extraction with an extractant, concentrating the resulting organic layer, then adding a crystallization solvent to dissolve same, then reducing the temperature for crystallization, and filtering and drying same to obtain a vitamin D3 ester crystal; re-dissolving same, subjecting same to saponification with lipase column B and extraction, returning the resulting organic layer to the lipase column B for saponification and extracting same, and continuing the cycle until the vitamin D3 ester residue in the organic layer is < 1 wt%; finally subjecting the organic layer to concentration, crystallization and drying to obtain a fine vitamin 3 crystal; and treating the crystallization mother liquor for reuse as the substrate.

Description

一种维生素D 3的提纯方法 A kind of vitamin D 3 purification method 技术领域Technical field
本发明涉及维生素领域,尤其涉及一种维生素D 3的提纯方法。 The present invention relates to the field of vitamins, particularly to a method for the purification of vitamin D 3.
背景技术Background technique
维生素D 3,又名胆骨化醇,具有促进肠道钙吸收、调节钙与磷的代谢、诱导骨质钙磷沉着的生理功能,可促进骨骼生长、防止佝偻病,大剂量也用于皮肤结核、皮肤及粘膜各型红斑狼疮等。 Vitamin D 3 , also known as cholecalciferol, has the physiological functions of promoting intestinal calcium absorption, regulating calcium and phosphorus metabolism, and inducing bone calcium and phosphorus deposition. It can promote bone growth and prevent rickets. Large doses are also used for skin tuberculosis. , Skin and mucous membranes of various types of lupus erythematosus, etc.
光化反应合成的维生素D 3含有副反应生成的速甾醇、光甾醇以及残余原料7-去氢胆固醇,一般仅能得到2000-3000万IU/g的维生素D 3,这些副产物因结构相似,性质相近,较难进一步分离、提纯。 Vitamin D 3 synthesized by photochemical reaction contains tachysterol, photosterol and residual raw material 7-dehydrocholesterol produced by side reactions. Generally, only 20-30 million IU/g of vitamin D 3 can be obtained. These by-products are similar in structure. Similar in nature, it is difficult to further separate and purify.
目前维生素D 3提纯方法主要有化学法和柱层析法,另外还有超临界CO 2柱分离法。化学法,例如US3157678A,原理是把光照产物制成相应的酯,利用酯化后物质结构差异引起的在溶剂中的溶解度差异,通过多次的结晶将杂质分离,再皂化为维生素D 3,而后进一步结晶提纯得到食品级维生素D 3,酯化反应剂主要为各类酰氯。采用化学法提纯维生素D 3,所用的酯化原料苯甲酰氯或丁酰氯等原料毒性大,过程中产生较多难处理的废水和废渣,另外化学法合成过程相对剧烈,收率也偏低,US3157678A所述方法为文献记载化学法最高收率,做到维生素D 3丁酯结晶步骤收率为72%。柱层析法,例如US3367950A,则是需要用层析柱分离,用大量溶剂进行洗脱得到主段,再浓缩更换溶剂进行结晶,得到高单位维生素D 3。柱层析法需要使用大量的溶剂进行洗脱,后续回收溶剂量较大,能耗高,过柱也会产生较多的固废,且整体收率不高,工业化成本大于化学法。超临界CO 2柱分离法,例如CN1240209A中提到的超临界法则是通过色谱柱使用超临界或液态二氧化碳,选用改性溶剂作流动相,改性硅胶作固定相进行分离,设备压力在7.0~15.0MPa。超临界柱分离法需要使用7MPa以上的高压设备,设备安全性要求高,且需要较贵的改性硅胶,工业化成本高,难以工业化应用。 At present, vitamin D 3 purification methods mainly include chemical methods and column chromatography, and there is also a supercritical CO 2 column separation method. The chemical method, such as US3157678A, is based on the principle that the illuminated product is made into the corresponding ester, and the difference in solubility in the solvent caused by the difference in the structure of the substance after esterification is used to separate impurities through multiple crystallizations, and then saponified into vitamin D 3 , and then Further crystallization and purification to obtain food-grade vitamin D 3 , the esterification reactant is mainly various acid chlorides. To purify vitamin D 3 by chemical method, the esterification raw materials such as benzoyl chloride or butyryl chloride are highly toxic and produce more difficult-to-treat waste water and waste residue. In addition, the chemical synthesis process is relatively violent, and the yield is also low. The method described in US3157678A is the highest yield of the chemical method recorded in the literature, and the yield of the vitamin D 3 butyl ester crystallization step is 72%. Column chromatography, such as US3367950A, requires separation by a chromatographic column, eluting with a large amount of solvent to obtain the main section, and then concentrating and replacing the solvent for crystallization to obtain high-unit vitamin D 3 . Column chromatography requires the use of a large amount of solvent for elution, the subsequent recovery of the solvent is large, the energy consumption is high, the column will also generate more solid waste, and the overall yield is not high, and the industrialization cost is greater than that of the chemical method. Supercritical CO 2 column separation method, for example, the supercritical method mentioned in CN1240209A is to use supercritical or liquid carbon dioxide through a chromatographic column, select a modified solvent as the mobile phase, and a modified silica gel as a stationary phase for separation. The equipment pressure is 7.0~ 15.0MPa. The supercritical column separation method requires the use of high-pressure equipment above 7MPa, the equipment safety requirements are high, and the more expensive modified silica gel is required, the industrialization cost is high, and it is difficult to industrialize the application.
发明内容Summary of the invention
本发明的目的在于提供一种高收率、低成本、环境友好的维生素D3的提纯方法。The purpose of the present invention is to provide a method for purifying vitamin D3 with high yield, low cost, and environmental friendliness.
为实现上述目的,本发明提供一种维生素D3的提纯方法,其特征在于,包括如下步骤:In order to achieve the above objective, the present invention provides a method for purifying vitamin D3, which is characterized in that it comprises the following steps:
S1.以维生素D 3粗品为底物,在非水相溶剂中与弱有机酸或酸酐混合,通过脂肪酶柱A进行酯化反应,得到含维生素D 3酯的酯化液; S1. Use the crude vitamin D 3 as a substrate, mix it with a weak organic acid or anhydride in a non-aqueous solvent, and perform an esterification reaction through lipase column A to obtain an esterified liquid containing vitamin D 3 ester;
S2.将所得含维生素D 3酯的酯化液用萃取剂进行萃取,残余酸进入水层,维生素D 3酯进入有机层,将有机层进行浓缩得到浓缩的维生素D 3酯; S2. Extract the obtained esterified liquid containing vitamin D 3 ester with an extractant, the residual acid enters the water layer, the vitamin D 3 ester enters the organic layer, and the organic layer is concentrated to obtain a concentrated vitamin D 3 ester;
S3.将浓缩的维生素D 3酯加入结晶溶剂溶解后降温结晶,过滤、烘干得到维生素D 3酯结晶;任选的,结晶的母液经浓缩、皂化、热异构后得到饲料级维生素D 3S3. Add the concentrated vitamin D 3 ester to the crystallization solvent to dissolve and then cool down and crystallize, filter and dry to obtain vitamin D 3 ester crystals; optionally, the crystalline mother liquor is concentrated, saponified, and thermally isomerized to obtain feed-grade vitamin D 3
S4.将所得的维生素D 3酯结晶用非水相溶剂溶解后,通过脂肪酶柱B进行皂化反应,得皂化液;将皂化液用水进行萃取,分离出的有机酸进入水层,有机层重回脂肪酶柱B再次皂化水解残存的维生素D 3酯,重复循环皂化-水解的步骤2~5次直至有机相中维生素D 3酯残存<1wt%后,停止循环; S4. After dissolving the obtained vitamin D 3 ester crystals in a non-aqueous solvent, the saponification reaction is carried out through the lipase column B to obtain a saponification liquid; the saponification liquid is extracted with water, and the separated organic acid enters the water layer, and the organic layer is heavy Return to the lipase column B to saponify and hydrolyze the remaining vitamin D 3 ester again, and repeat the cycle of saponification-hydrolysis step 2 to 5 times until the residual vitamin D 3 ester in the organic phase is less than 1wt%, then stop the circulation;
S5.将有机层进行浓缩、结晶、烘干,得维生素D 3结晶精品; S5. Concentrate, crystallize, and dry the organic layer to obtain vitamin D 3 crystal products;
任选的,结晶的母液经浓缩、热异构后作为S1步骤的底物利用。Optionally, the crystallization mother liquor is used as the substrate of step S1 after being concentrated and thermally isomerized.
进一步,所述S1步骤中的维生素D 3粗品的含量为1500-3500IU/g; Further, the content of the crude vitamin D 3 in the step S1 is 1500-3500 IU/g;
任选的,所述S1步骤中的底物与非水相溶剂的重量体积比为1g:(5~30)ml,优选1g:8ml。Optionally, the weight-volume ratio of the substrate to the non-aqueous phase solvent in the S1 step is 1 g: (5-30) ml, preferably 1 g: 8 ml.
任选的,所述S1步骤和S4步骤中,所述的非水相溶剂各自独立地为烷烃、卤代烃或芳香烃;优选的,所述烷烃选自正己烷、戊烷、庚烷、环己烷和石油醚中的至少一种。Optionally, in the S1 step and S4 step, the non-aqueous solvent is each independently an alkane, a halogenated hydrocarbon or an aromatic hydrocarbon; preferably, the alkane is selected from n-hexane, pentane, heptane, At least one of cyclohexane and petroleum ether.
进一步,所述S1步骤中,底物与弱有机酸的摩尔比为1:(1.0~10);优选的,所述底物与弱有机酸的摩尔比为1:1.1;Further, in the step S1, the molar ratio of the substrate to the weak organic acid is 1:(1.0-10); preferably, the molar ratio of the substrate to the weak organic acid is 1:1.1;
任选的,所述弱有机酸为丁酸、戊酸或月桂酸。Optionally, the weak organic acid is butyric acid, valeric acid or lauric acid.
进一步,所述S1步骤中,所述酸酐为正丁酸酐、丁二酸酐或戊酸酐;Further, in the step S1, the acid anhydride is n-butyric anhydride, succinic anhydride or valeric anhydride;
任选的,所述底物与酸酐的摩尔比为1:(0.5~5);优选的,所述底物与酸酐的摩尔比为1:0.55;Optionally, the molar ratio of the substrate to the acid anhydride is 1:(0.5-5); preferably, the molar ratio of the substrate to the acid anhydride is 1:0.55;
任选的,所述酯化反应的温度为20~50℃,优选35℃;Optionally, the temperature of the esterification reaction is 20-50°C, preferably 35°C;
任选的,所述通过脂肪酶柱A时物料在柱内的停留时间为0.5~5小时,优选的,为1 小时。Optionally, the residence time of the material in the column when passing through the lipase column A is 0.5-5 hours, preferably, 1 hour.
进一步,所述S2步骤中,所述萃取剂为水或含水甲醇;优选的,所述含水甲醇中甲醇的体积含量为0~98%,更优选的,所述含水甲醇中甲醇的体积含量为95%;Further, in the step S2, the extractant is water or aqueous methanol; preferably, the volume content of methanol in the aqueous methanol is 0-98%, and more preferably, the volume content of methanol in the aqueous methanol is 95%;
任选的,所述萃取剂与含维生素D 3酯的酯化液的进料体积比为(0.2~3):1;优选的,所述萃取剂与含维生素D 3酯的酯化液的进料体积比为0.8:1。 Optionally, the feed volume ratio of the extractant to the esterification liquid containing vitamin D 3 ester is (0.2~3):1; preferably, the ratio of the extractant to the esterification liquid containing vitamin D 3 ester The feed volume ratio is 0.8:1.
进一步,所述S2步骤和S4步骤中的萃取操作在萃取塔中进行。Further, the extraction operations in the S2 step and the S4 step are performed in an extraction tower.
进一步,所述S3步骤中,所述结晶溶剂为酮类或醇类溶剂;优选的,所述结晶溶剂为丙酮;Further, in the step S3, the crystallization solvent is a ketone or alcohol solvent; preferably, the crystallization solvent is acetone;
任选的,所述结晶的温度为-5~-30℃,优选的,所述结晶的温度为-20℃;Optionally, the crystallization temperature is -5 to -30°C, preferably, the crystallization temperature is -20°C;
任选的,浓缩的维生素D 3酯与结晶溶剂的比例为1g:(0.7~5)ml,优选1g:1ml。 Optionally, the ratio of the concentrated vitamin D 3 ester to the crystallization solvent is 1 g: (0.7-5) ml, preferably 1 g: 1 ml.
进一步,所述S4步骤中,所述维生素D 3酯结晶与非水相溶剂的质量体积比例为1g:(2~30)ml,优选1g:5ml; Further, in the step S4, the mass-volume ratio of the vitamin D 3 ester crystal to the non-aqueous solvent is 1 g: (2-30) ml, preferably 1 g: 5 ml;
任选的,所述皂化反应的温度为20~50℃,优选35℃。Optionally, the temperature of the saponification reaction is 20-50°C, preferably 35°C.
进一步,所述S5步骤中,所述结晶的溶剂为甲酸甲酯或者乙酸乙酯,任选的,所述结晶的温度为0~10℃,保温3小时以上;Further, in the step S5, the solvent of the crystallization is methyl formate or ethyl acetate, optionally, the temperature of the crystallization is 0-10°C, and the temperature is kept for more than 3 hours;
任选的,所述有机层进行浓缩所得的浓缩物与结晶溶剂的质量体积比例为1g:(4~20)ml,优选1g:6ml。Optionally, the mass-volume ratio of the concentrate obtained by concentrating the organic layer to the crystallization solvent is 1 g: (4-20) ml, preferably 1 g: 6 ml.
进一步,所述S1步骤和S4步骤中,所述脂肪酶柱A和脂肪酶柱B中的脂肪酶为经固定化处理的南极假丝酵母脂肪酶B,优选的,各自独立地为诺维信435固定化脂肪酶,或采用CN105462952A中公开的固定化方法处理的南极假丝脂肪酶B;Further, in the step S1 and the step S4, the lipase in the lipase column A and the lipase column B is an immobilized Candida antarctica lipase B, preferably, each independently is Novozymes 435 immobilized lipase, or Candida Antarctica lipase B treated by the immobilization method disclosed in CN105462952A;
优选的,所述S1步骤中,所述底物与脂肪酶柱A中的脂肪酶的质量比为1:(0.2~30),优选1:(0.5-2);Preferably, in the step S1, the mass ratio of the substrate to the lipase in the lipase column A is 1:(0.2-30), preferably 1:(0.5-2);
任选的,所述S4步骤中,所述维生素D 3酯结晶与脂肪酶柱B中的脂肪酶的质量比为1:(0.2~30),优选1:(0.5-2)。 Optionally, in the step S4, the mass ratio of the vitamin D 3 ester crystal to the lipase in the lipase column B is 1:(0.2-30), preferably 1:(0.5-2).
本发明可处理的底物原料可选为1500-3500IU/g范围。含量太低酯化结晶效果差,且容易使酶活较快下降,影响脂肪酶套用次数,含量太高则可能不需要酯化,可通过结晶直接提纯。The substrate material that can be processed in the present invention can be selected in the range of 1500-3500 IU/g. If the content is too low, the effect of esterification and crystallization is poor, and the enzyme activity is likely to decrease quickly, which affects the number of times of lipase application. If the content is too high, esterification may not be required, and it can be purified directly by crystallization.
本发明针对目前工业化成本相对较低的化学合成法存在问题进行改进,创新性地采用了酶酰化法进行维生素D 3酯化反应,然后经过结晶提纯得到纯度较高的维生素D 3酯,接着利用酶酰化反应的可逆性,将维生素D 3酯结晶用酶皂化为维生素D 3,最后结晶得到高单位维生素D 3。本发明使用酶法进行酯化、皂化,不再使用毒性大的原料,且酶可重复使用,部分原料能够回收,循环利用,无固废排放,符合绿色化学理念,由于酶酰化反应更温和,收率较化学法有所提高,工业化应用成本更低。 The present invention improves on the problems of the current chemical synthesis method with relatively low industrialization cost, innovatively adopts the enzyme acylation method to carry out the vitamin D 3 esterification reaction, and then obtains the higher purity vitamin D 3 ester through crystallization and purification, and then Utilizing the reversibility of the enzyme acylation reaction, the vitamin D 3 ester crystal is saponified into vitamin D 3 by enzyme, and finally high unit vitamin D 3 is obtained by crystallization. The invention uses enzymatic method for esterification and saponification, no more toxic raw materials, enzymes can be reused, some raw materials can be recovered, recycled, no solid waste is discharged, conform to the concept of green chemistry, and the enzyme acylation reaction is more gentle , The yield is improved compared with chemical method, and the cost of industrial application is lower.
全过程维生素D 3结晶收率50~75.3%,加上各结晶母液中的维生素D 3,折纯维生素D 3回收率为90~97%,即全过程维生素D 3损耗3~10%。 The crystallization yield of vitamin D 3 in the whole process is 50-75.3%, plus the vitamin D 3 in each crystallization mother liquor, the recovery rate of pure vitamin D 3 is 90-97%, that is, the loss of vitamin D 3 in the whole process is 3-10%.
所述脂肪酶柱A和脂肪酶柱B为不锈钢或其他耐溶剂材质管道加工圆柱形柱子,外形如附图1所示但尺寸不限于附图标注,进出口放置滤纸和脱脂棉花防止酶被溶液带出,所用脂肪酶为经固定化处理的南极假丝酵母脂肪酶B,例如可以为诺维信435固定化脂肪酶(Novozym R435),或者采用CN105462952A中公开的固定化方法处理的南极假丝脂肪酶B。脂肪酶套用次数达40次以上。 The lipase column A and lipase column B are stainless steel or other solvent-resistant material pipe processing cylindrical columns, the shape is shown in Figure 1 but the size is not limited to the drawings, filter paper and defatted cotton are placed at the inlet and outlet to prevent enzymes from being solution Take out, the lipase used is immobilized Candida antarctica lipase B, for example, it can be Novozymes 435 immobilized lipase (Novozym R 435), or the Antarctic pseudolipase treated with the immobilization method disclosed in CN105462952A Silk Lipase B. Lipase is applied more than 40 times.
所述维生素D 3结晶检测根据2015年版《中国药典》方法检测比旋度和吸收系数,根据《中国药典》通则0722维生素D测定法测定产品含量。 The vitamin D 3 crystal detection is based on the 2015 edition of the "Chinese Pharmacopoeia" method to detect specific rotation and absorption coefficient, and the product content is determined based on the "Chinese Pharmacopoeia" general rule 0722 Vitamin D determination method.
本发明采用脂肪酶法进行维生素D 3的酯化,在非水相溶剂中维生素D 3原料与过量弱有机酸或酸酐混合,使用脂肪酶进行酯化反应。 The present invention uses lipase catalysts for esterification of vitamin D 3, vitamin D 3 or a weak organic acid with an excess of the raw material mixed acid anhydride, an esterification reaction using a lipase in a non-aqueous solvent.
本发明采用萃取塔萃取去除反应多余的酸。经分离后多余酸可继续套用于酯化。The invention uses an extraction tower to extract and remove excess acid from the reaction. After separation, the excess acid can continue to be used for esterification.
本发明利用酶酯化反应的可逆性,在非水相溶剂中使用脂肪酶皂化水解维生素D 3酯,并结合萃取塔萃取出水解产出的酸,有机相循环通过脂肪酶柱,促进可逆反应朝水解方向进行,最终使水解率达99%以上。萃取出的有机酸经分离后可套用至酯化反应,达到循化利用。 The invention utilizes the reversibility of the enzyme esterification reaction, uses lipase in the non-aqueous phase solvent to saponify and hydrolyze vitamin D 3 ester, and combines the extraction tower to extract the acid produced by the hydrolysis, and the organic phase circulates through the lipase column to promote the reversible reaction Proceed in the direction of hydrolysis, and finally the hydrolysis rate will reach 99% or more. After separation, the extracted organic acid can be applied to the esterification reaction to achieve recycling utilization.
本发明的有益效果:The beneficial effects of the present invention:
1、本发明创造性的采用脂肪酶法替代原化学法对原料维生素D 3进行酯化,避免使用高毒、强腐蚀性的苯甲酰氯、丁酰氯等原料。 1. The present invention creatively adopts the lipase method instead of the original chemical method to esterify the raw material vitamin D 3 , avoiding the use of highly toxic and corrosive benzoyl chloride, butyryl chloride and other raw materials.
2、反应采用脂肪酶酯化、皂化,过程较化学法温和,收率明显提高。仅酯化结晶步骤较化学法最高的72%提高了8%以上。2. The reaction adopts lipase esterification and saponification, the process is milder than the chemical method, and the yield is obviously improved. Only the esterification and crystallization step has increased by more than 8% compared with the highest 72% in the chemical method.
3、反应萃取的水层中酸可分离后回收使用,相对于化学法,没有难处理的废渣和较多 有害的废水排放,脂肪酶可多次循环使用,符合绿色环保的新工业需求。3. The acid in the water layer of the reaction extraction can be separated and recycled. Compared with the chemical method, there are no difficult-to-treat waste residues and more harmful waste water discharge. Lipase can be recycled many times, which meets the needs of green and environmental protection new industries.
4、利用脂肪酶酯化的可逆性,结合萃取塔,循环过柱水解,替代化学法使用强碱进行水解,过程更温和,水解出的酸可回收使用,减少原料使用。4. Utilizing the reversibility of lipase esterification, combined with extraction tower, circulating column hydrolysis, instead of chemical method using strong alkali for hydrolysis, the process is gentler, and the hydrolyzed acid can be recycled and used to reduce the use of raw materials.
5、本发明产出的维生素D 3结晶精品的单位超过3900万IU/g,检测指标符合《中国药典》要求。 5. The unit of the vitamin D 3 crystal product produced by the present invention exceeds 39 million IU/g, and the detection index meets the requirements of the Chinese Pharmacopoeia.
综上所述,相较原来工业化成本最低的化学法,本发明收率更高,无高毒原料使用,原料可大部分循环使用,避免废渣和难处理废水的排放,是一种更绿色环保,成本更低更经济的维生素D 3提纯方法。 In summary, compared with the chemical method with the lowest industrialization cost, the present invention has higher yield, no high-toxic raw materials, and most of the raw materials can be recycled, avoiding the discharge of waste residues and difficult-to-treat wastewater, and is a greener and more environmentally friendly method. , A lower cost and more economical method for purification of vitamin D 3.
附图说明Description of the drawings
图1是本发明的具体实施方式的脂肪酶柱A和脂肪酶柱B的结构示意图。Fig. 1 is a schematic diagram of the structure of a lipase column A and a lipase column B according to a specific embodiment of the present invention.
图2是本发明的具体实施方式的流程简图。Fig. 2 is a schematic flowchart of a specific embodiment of the present invention.
具体实施方式detailed description
下面详细描述本发明的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,旨在用于解释本发明,而不能理解为对本发明的限制。实施例中未注明具体技术或条件者,按照本领域内的文献所描述的技术或条件或者按照产品说明书进行。所用试剂或仪器未注明生产厂商者,均为可以通过市购获得的常规产品。The embodiments of the present invention are described in detail below. Examples of the embodiments are shown in the accompanying drawings, in which the same or similar reference numerals indicate the same or similar elements or elements with the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary, and are intended to explain the present invention, but should not be construed as limiting the present invention. Where specific techniques or conditions are not indicated in the examples, the procedures shall be carried out in accordance with the techniques or conditions described in the literature in the field or in accordance with the product specification. The reagents or instruments used without the manufacturer's indication are all conventional products that can be purchased on the market.
以下实施例结合附图1-2进行说明和理解。The following embodiments are described and understood with reference to FIGS. 1-2.
图2中若采用的非水相溶剂密度高于萃取剂时(如采用的非水相溶剂为卤代烃),萃取塔变为有机相上进下出,水相下进上出。In Figure 2, if the density of the non-aqueous solvent used is higher than that of the extractant (for example, the non-aqueous solvent used is a halogenated hydrocarbon), the extraction tower becomes the organic phase, which enters and exits from the top, and the water phase enters and exits from the bottom.
实施例1Example 1
在溶解釜内投入树脂状维生素D 3粗品(单位2550万IU/g)20g(0.052mol),加入5.04g(0.057mol)丁酸,160ml正己烷溶解,用泵以0.65ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱A(停留时间1h),过柱温度35℃,得到酯化液,转化率99.5%,用泵按甲醇水:酯化液体积流量比0.8:1分别往萃取塔A打入95%含水甲醇和酯化液进行萃取, 得到上层有机相,控制内温小于35℃浓缩干,浓缩得到的正己烷可重复利用,得到维生素D 3酯,用24ml丙酮溶解后缓慢降温至-20℃,静置3小时,过滤洗涤烘干得到98.8%维生素D 3酯12.79g,维生素D 3酯总收率83.8%。母液浓缩干后皂化异构得饲料级维生素D 3 832.8万IU/g,重量6.89g。维生素D 3酯12.79g用64ml正己烷溶解后按1ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;萃取后有机相重新按1ml/min流量通过脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;如此循环3次后,取样检测维生素D 3酯残存<1wt%后停止过柱,萃取剩余溶液后得到有机相,有机相35℃以下浓缩后得维生素D 3 11.40g,单位3688万IU/g,皂化收率98.4%,浓缩得到的正己烷可重复利用。维生素D 3加入乙酸乙酯69ml溶解,通过洁净过滤器过滤后,开始缓慢降温结晶,降温至5℃后,保温3小时,过滤,用冷乙酸乙酯洗涤后,烘干结晶,得到9.61g维生素D 3结晶精品,单位3995万IU/g,比旋度+110°,吸收系数471。母液浓缩异构后得维生素D 3脚料1.79g,单位2042万IU/g,套用至酯化步骤。全过程维生素D 3结晶收率75.3%,加上各结晶母液所含维生素D 3,折纯维生素D 3回收率96.7%。 Put 20g (0.052mol) of crude resinous vitamin D 3 (unit 25.5 million IU/g) into the dissolving kettle, add 5.04g (0.057mol) butyric acid, 160ml n-hexane to dissolve, and use a pump to pass through the water at a flow rate of 0.65ml/min. 20g Novozymes 435 DN10×500 lipase column A (residence time 1h), the column temperature is 35℃, the esterification liquid is obtained, the conversion rate is 99.5%, and the volume flow ratio of methanol water: esterification liquid is 0.8:1 with a pump Pour 95% water-containing methanol and esterification liquid into extraction tower A to obtain the upper organic phase. Control the internal temperature to be less than 35℃ and concentrate to dryness. The n-hexane obtained by concentration can be reused to obtain vitamin D 3 ester. Use 24ml of acetone. After dissolution, the temperature was slowly lowered to -20°C, and it was allowed to stand for 3 hours, filtered, washed and dried to obtain 12.79 g of 98.8% vitamin D 3 ester, and the total yield of vitamin D 3 ester was 83.8%. After the mother liquor is concentrated and dried, it is saponified and isomerized to obtain feed-grade vitamin D 3 8.328 million IU/g, weighing 6.89 g. Vitamin D 3 ester 12.79g was dissolved in 64ml n-hexane and passed through a DN10×500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature was 35℃. After the column was passed, the pump was pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C. After the column is passed, the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester is less than 1wt%, stop passing the column. After extracting the remaining solution, the organic phase is obtained. After the organic phase is concentrated below 35°C , 11.40g of vitamin D 3 is obtained, the unit is 36.88 million IU/g, the saponification yield is 98.4%, and the n-hexane obtained by concentration Can be reused. Vitamin D 3 was dissolved in 69ml of ethyl acetate, filtered through a clean filter, and then slowly cooled and crystallized. After cooling to 5°C, the temperature was kept for 3 hours, filtered, washed with cold ethyl acetate, dried and crystallized to obtain 9.61g of vitamins. D 3 crystal product, unit 39.95 million IU/g, specific rotation +110°, absorption coefficient 471. After the mother liquor is concentrated and isomerized, 1.79 g of vitamin D 3 scraps are obtained, with a unit of 20.42 million IU/g, which is applied to the esterification step. The crystallization yield of vitamin D 3 in the whole process is 75.3%, plus the vitamin D 3 contained in each crystallization mother liquor, the recovery rate of pure vitamin D 3 is 96.7%.
实施例2Example 2
在溶解釜内投入树脂状维生素D 3粗品(单位2550万IU/g)20g(0.052mol),加入6.87g(0.078mol)丁酸,160ml正己烷溶解,用泵以0.65ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱A(停留时间1h),过柱温度35℃,得到酯化液,转化率99.8%,用泵按甲醇水:酯化液体积流量比0.8:1分别往萃取塔A打入95%含水甲醇和酯化液进行萃取,得到上层有机相,控制内温小于35℃浓缩干,浓缩得到的正己烷可重复利用,得到维生素D 3酯,用24ml丙酮溶解后缓慢降温至-20℃,静置3小时,过滤洗涤烘干得到98.6%维生素D 3酯12.50g,维生素D 3酯总收率81.8%。母液浓缩干后皂化异构得饲料级维生素D 3 839.73万IU/g,重量6.91g。维生素D 3酯12.50g用63ml正己烷溶解后按1ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;萃取后有机相重新按1ml/min流量通过脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;如此循环3次后,取样检测维生素D 3酯残存<wt 1%后停止过柱,萃取剩余溶液后得到有机相,有机相35℃以下浓缩后得维生素D 3 11.34g,单位3624万IU/g, 皂化收率98.5%,浓缩得到的正己烷可重复利用。维生素D 3加入乙酸乙酯68ml溶解,通过洁净过滤器过滤后,开始缓慢降温结晶,降温至5℃后,保温3小时,过滤,用冷乙酸乙酯洗涤后,烘干结晶,得到9.48g维生素D 3结晶精品,单位3942万IU/g,比旋度+111°,吸收系数473。母液浓缩异构后得维生素D 3脚料1.86g,单位2007万IU/g,套用至酯化步骤。全过程维生素D 3结晶收率73.2%,加上各结晶母液中维生素D 3,折纯维生素D 3回收率95.0%。 Put 20g (0.052mol) of crude resinous vitamin D 3 (unit 25.5 million IU/g) into the dissolving kettle, add 6.87g (0.078mol) butyric acid, and dissolve with 160ml n-hexane, and use a pump to pass through the water at a flow rate of 0.65ml/min. 20g Novozymes 435 DN10×500 lipase column A (residence time 1h), the column temperature is 35℃, the esterification liquid is obtained, the conversion rate is 99.8%, and the volume flow ratio of methanol water: esterification liquid is 0.8:1 with a pump Pour 95% aqueous methanol and esterification liquid into extraction tower A to extract the upper organic phase. Control the internal temperature to be less than 35°C and concentrate to dry. The concentrated n-hexane can be reused to obtain vitamin D 3 ester. Use 24ml of acetone. After dissolving, the temperature was slowly lowered to -20°C, and it was allowed to stand for 3 hours, filtered, washed and dried to obtain 12.50 g of 98.6% vitamin D 3 ester, and the total yield of vitamin D 3 ester was 81.8%. After the mother liquor is concentrated and dried, it is saponified and isomerized to obtain feed-grade vitamin D 3 8,397,300 IU/g, with a weight of 6.91g. Vitamin D 3 ester 12.50g is dissolved in 63ml n-hexane and passed through a DN10×500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature is 35℃. After the column is passed, the pump is pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C. After the column is passed, the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester <wt 1%, stop passing the column, extract the remaining solution to obtain the organic phase. After the organic phase is concentrated below 35°C , 11.34g of vitamin D 3 is obtained, the unit is 36.24 million IU/g, and the saponification yield is 98.5%. Alkane can be reused. Vitamin D 3 was dissolved by adding 68ml ethyl acetate, filtered through a clean filter, and then slowly cooled to crystallize. After cooling to 5°C, keep it for 3 hours, filter, wash with cold ethyl acetate, dry and crystallize to obtain 9.48g vitamins D 3 crystal product, unit 39.42 million IU/g, specific rotation +111°, absorption coefficient 473. After the mother liquor is concentrated and isomerized, 1.86 g of vitamin D 3 scraps are obtained, the unit is 20.07 million IU/g, which is applied to the esterification step. The crystallization yield of vitamin D 3 in the whole process is 73.2%, plus the vitamin D 3 in each crystallization mother liquor, the recovery rate of pure vitamin D 3 is 95.0%.
实施例3Example 3
在溶解釜内投入树脂状维生素D 3粗品(单位2550万IU/g)20g(0.052mol),加入4.52g(0.029mol)丁酸酐,160ml正己烷溶解,用泵以0.65ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱A(停留时间1h),过柱温度35℃,得到酯化液,转化率99.6%,用泵按甲醇水:酯化液体积流量比0.8:1分别往萃取塔A打入95%含水甲醇和酯化液进行萃取,得到上层有机相,控制内温小于35℃浓缩干,浓缩得到的正己烷可重复利用,得到维生素D 3酯,用24ml丙酮溶解后缓慢降温至-20℃,静置3小时,过滤洗涤烘干得到98.8%维生素D 3酯12.80g,维生素D 3酯总收率83.9%。母液浓缩干后皂化异构得饲料级维生素D 3 833.2万IU/g,重量6.89g。维生素D 3酯12.8g用64ml正己烷溶解后按1ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;萃取后有机相重新按1ml/min流量通过脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;如此循环3次后,取样检测维生素D 3酯残存<wt 1%后停止过柱,萃取剩余溶液后得到有机相,有机相35℃以下浓缩后得维生素D 3 11.51g,单位3661万IU/g,皂化收率98.5%,浓缩得到的正己烷可重复利用。维生素D 3加入乙酸乙酯69ml溶解,通过洁净过滤器过滤后,开始缓慢降温结晶,降温至5℃后,保温3小时,过滤,用冷乙酸乙酯洗涤后,烘干结晶,得到9.62g维生素D 3结晶精品,单位3970万IU/g,比旋度+111°,吸收系数477。母液浓缩异构后得维生素D 3脚料1.82g,单位2015万IU/g,套用至酯化步骤。全过程维生素D 3结晶收率75.4%,加上各结晶母液中维生素D 3,折纯维生素D 3回收率96.9%。 Put 20g (0.052mol) of crude resinous vitamin D 3 (unit 25.5 million IU/g) into the dissolving kettle, add 4.52g (0.029mol) butyric anhydride, and dissolve it with 160ml n-hexane. Use a pump to pass through the water at a flow rate of 0.65ml/min. 20g Novozymes 435 DN10×500 lipase column A (residence time 1h), and the column temperature is 35℃, and the esterification liquid is obtained, the conversion rate is 99.6%, and the volume flow ratio of methanol water: esterification liquid is 0.8:1 with a pump. Pour 95% aqueous methanol and esterification liquid into extraction tower A to extract the upper organic phase. Control the internal temperature to be less than 35°C and concentrate to dry. The concentrated n-hexane can be reused to obtain vitamin D 3 ester. Use 24ml of acetone. After dissolving, the temperature was slowly lowered to -20°C, and it was allowed to stand for 3 hours, filtered, washed and dried to obtain 12.80 g of 98.8% vitamin D 3 ester, and the total yield of vitamin D 3 ester was 83.9%. After the mother liquor is concentrated and dried, it is saponified and isomerized to obtain feed-grade vitamin D 3 8.332 million IU/g, weighing 6.89 g. 12.8g vitamin D 3 ester is dissolved in 64ml n-hexane and passed through the DN10×500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature is 35℃. After the column is passed, the pump is pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C. After the column is passed, the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester is <wt 1%, stop passing the column. After extracting the remaining solution, the organic phase is obtained. After the organic phase is concentrated below 35°C , 11.51g of vitamin D 3 is obtained, the unit is 36.61 million IU/g, and the saponification yield is 98.5%. Alkane can be reused. Vitamin D 3 was dissolved in 69ml of ethyl acetate, filtered through a clean filter, and then slowly cooled and crystallized. After cooling to 5°C, the temperature was kept for 3 hours, filtered, washed with cold ethyl acetate, dried and crystallized to obtain 9.62g vitamins D 3 crystal product, unit 39.7 million IU/g, specific rotation +111°, absorption coefficient 477. After the mother liquor is concentrated and isomerized, 1.82 g of vitamin D 3 scraps are obtained, with a unit of 20.05 million IU/g, which is applied to the esterification step. The crystallization yield of vitamin D 3 in the whole process is 75.4%, plus the vitamin D 3 in each crystallization mother liquor, and the recovery rate of pure vitamin D 3 is 96.9%.
实施例4Example 4
在溶解釜内投入树脂状维生素D 3粗品(单位2550万IU/g)20g(0.052mol),加入6.58g(0.042mol)丁酸酐,160ml正己烷溶解,用泵以0.65ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱A(停留时间1h),过柱温度35℃,得到酯化液,转化率99.8%,用泵 按甲醇水:酯化液体积流量比0.8:1分别往萃取塔A打入95%含水甲醇和酯化液进行萃取,得到上层有机相,控制内温小于35℃浓缩干,浓缩得到的正己烷可重复利用,得到维生素D 3酯,用24ml丙酮溶解后缓慢降温至-20℃,静置3小时,过滤洗涤烘干得到98.5%维生素D 3酯12.51g,维生素D 3酯总收率81.8%。母液浓缩干后皂化异构得饲料级维生素D 3 820.79万IU/g,重量6.84g。维生素D 3酯12.51g用63ml正己烷溶解后按1ml/min流量通过含20g诺维信435的DN10×500脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;萃取后有机相重新按1ml/min流量通过脂肪酶柱B,过柱温度35℃,过柱后泵打入萃取塔B中用水萃取分离;如此循环3次后,取样检测维生素D 3酯残存<wt 1%后停止过柱,萃取剩余溶液后得到有机相,有机相35℃以下浓缩后得维生素D 3 11.34g,单位3610万IU/g,皂化收率98.2%,浓缩得到的正己烷可重复利用。维生素D 3加入乙酸乙酯68ml溶解,通过洁净过滤器过滤后,开始缓慢降温结晶,降温至5℃后,保温3小时,过滤,用冷乙酸乙酯洗涤后,烘干结晶,得到9.23g维生素D 3结晶精品,单位3935万IU/g,比旋度+110°,吸收系数474。母液浓缩异构后得维生素D 3脚料1.96g,单位2051万IU/g,套用至酯化步骤。全过程维生素D 3结晶收率72.4%,加上各结晶母液中维生素D 3,折纯维生素D 3回收率94.2%。 Put 20g (0.052mol) of crude resinous vitamin D 3 (unit 25.5 million IU/g) into the dissolving kettle, add 6.58g (0.042mol) butyric anhydride, and dissolve with 160ml n-hexane, and use a pump to pass through the water at a flow rate of 0.65ml/min. 20g Novozymes 435 DN10×500 lipase column A (residence time 1h), the column temperature is 35℃, the esterification liquid is obtained, the conversion rate is 99.8%, and the volume flow ratio of methanol water: esterification liquid is 0.8:1 with a pump Pour 95% aqueous methanol and esterification liquid into extraction tower A to extract the upper organic phase. Control the internal temperature to be less than 35°C and concentrate to dry. The concentrated n-hexane can be reused to obtain vitamin D 3 ester. Use 24ml of acetone. After dissolution, the temperature was slowly lowered to -20°C, and it was allowed to stand for 3 hours, filtered, washed and dried to obtain 12.51 g of 98.5% vitamin D 3 ester, and the total yield of vitamin D 3 ester was 81.8%. The mother liquor is concentrated and dried and then saponified and isomerized to obtain feed grade vitamin D 3 8,207,900 IU/g, weight 6.84g. Vitamin D 3 ester 12.51g was dissolved in 63ml n-hexane and passed through a DN10×500 lipase column B containing 20g Novozymes 435 at a flow rate of 1ml/min. The column temperature was 35℃. After the column was passed, the pump was pumped into the extraction tower B with water Extraction separation; after extraction, the organic phase passes through lipase column B again at a flow rate of 1ml/min, and the column temperature is 35°C. After the column is passed, the pump is pumped into extraction tower B for extraction and separation with water; after this cycle 3 times, take a sample to detect vitamin D 3 After the residual ester <wt 1%, stop passing the column, extract the remaining solution to obtain the organic phase. After the organic phase is concentrated below 35°C , 11.34g of vitamin D 3 is obtained, the unit is 36.1 million IU/g, and the saponification yield is 98.2%. Alkane can be reused. Vitamin D 3 was dissolved by adding 68ml ethyl acetate. After filtering through a clean filter, it began to slowly cool down and crystallize. After cooling to 5°C, keep it for 3 hours, filter, wash with cold ethyl acetate, dry and crystallize to obtain 9.23g vitamins D 3 crystal product, unit 39.35 million IU/g, specific rotation +110°, absorption coefficient 474. After the mother liquor is concentrated and isomerized, 1.96 g of vitamin D 3 scraps are obtained, with a unit of 20.51 million IU/g, which is applied to the esterification step. The crystallization yield of vitamin D 3 in the whole process was 72.4%, plus the vitamin D 3 in each crystallization mother liquor, the recovery rate of pure vitamin D 3 was 94.2%.
实施例5Example 5
酯化溶剂使用400ml,其余同实施例1,酯化得到99.0%维生素D 3丁酯12.40g,最终得到维生素D 3结晶精品9.43g,单位3956万IU/g,比旋度+107°,吸收系数480。结晶总收率73.3%,维生素D 3总回收率93.9%。 The esterification solvent used 400ml, and the rest were the same as in Example 1. The esterification yielded 12.40g of 99.0% vitamin D 3 butyl ester, and finally 9.43g of vitamin D 3 crystal product, with a unit of 39.56 million IU/g, specific rotation +107°, absorption The coefficient is 480. The total yield of crystallization is 73.3%, and the total recovery of vitamin D 3 is 93.9%.
实施例6Example 6
酯化用丁酸改为戊酸5.84g(0.057mol),其余同实施例1,酯化得到98.8%维生素D 3戊酯12.03g,最终得到维生素D 3结晶精品8.34g,单位3962万IU/g,比旋度+108°,吸收系数469。结晶总收率64.8%,维生素D 3总回收率91.9%。 The butyric acid used for esterification was changed to 5.84g (0.057mol) of valeric acid, and the rest was the same as in Example 1. The esterification yielded 12.03g of 98.8% vitamin D 3 amyl ester, and finally 8.34g of vitamin D 3 crystals, with a unit of 39.62 million IU/ g, specific rotation +108°, absorption coefficient 469. The total yield of crystallization is 64.8%, and the total recovery of vitamin D 3 is 91.9%.
实施例7Example 7
过柱温度改用45℃,其余同实施例1,酯化得到99.0%维生素D 3丁酯12.23g,最终得到维生素D 3结晶精品9.22g,单位3945万IU/g,比旋度+108°,吸收系数475。结晶总收率71.3%,维生素D 3总回收率91.5%。 The column temperature was changed to 45°C, and the rest was the same as in Example 1. The esterification yielded 12.23g of 99.0% vitamin D 3 butyl ester, and finally 9.22g of vitamin D 3 crystal product, the unit was 39.45 million IU/g, and the specific rotation was +108° , Absorption coefficient 475. The total yield of crystallization is 71.3%, and the total recovery of vitamin D 3 is 91.5%.
实施例8Example 8
脂肪酶用量改10g,其余同实施例1,酯化转化率为98.5%,得到99.1%维生素D 3丁酯12.36g;皂化水解步骤循环4次后检测合格最终得到维生素D 3结晶精品9.30g,单位3979万IU/g,比旋度+110°,吸收系数483。结晶总收率72.5%,维生素D 3总回收率93.48%。 The dosage of lipase was changed to 10g, and the rest was the same as in Example 1. The esterification conversion rate was 98.5%, and 12.36g of 99.1% vitamin D 3 butyl ester was obtained; after the saponification and hydrolysis step was cycled 4 times, the test was qualified and finally 9.30g of vitamin D 3 crystal was obtained. The unit is 39.79 million IU/g, the specific rotation is +110°, and the absorption coefficient is 483. The total yield of crystallization is 72.5%, and the total recovery of vitamin D 3 is 93.48%.
实施例9Example 9
脂肪酶用量改10g,其余同实施例3,酯化转化率较实施例1变为98.8%,得到99.2%维生素D 3丁酯12.61g;皂化水解步骤循环4次后检测合格最终得到维生素D 3结晶精品9.51g,单位3980万IU/g,比旋度+109°,吸收系数479。结晶总收率74.2%,维生素D 3总回收率95.19%。 The dosage of lipase was changed to 10g, and the rest was the same as in Example 3. The esterification conversion rate was 98.8% compared with Example 1, and 12.61g of 99.2% vitamin D 3 butyl ester was obtained. After the saponification and hydrolysis step was repeated 4 times, the test was qualified and finally vitamin D 3 was obtained. The crystal is 9.51g, the unit is 39.8 million IU/g, the specific rotation is +109°, and the absorption coefficient is 479. The total yield of crystallization is 74.2%, and the total recovery of vitamin D 3 is 95.19%.
以上实施例采用脂肪酶柱A和脂肪酶柱B为DN10不锈钢管道加工的DN10×500柱子进出口放置滤纸和棉花防止酶带出,所用酶为诺维信435脂肪酶,酶活10000U/g。以实施例1方案做酶套用实验40次,酶仍有较高效率,脂肪酶柱A检测酶活7230U/g,脂肪酶柱B检测酶活8243U/g。水洗萃取塔为实验室玻璃塔节加丝网填料搭建而成,其余过滤、浓缩等步骤均为实验室常用仪器。In the above embodiment, lipase column A and lipase column B are DN10×500 columns processed with DN10 stainless steel pipes. Filter paper and cotton are placed at the entrance and exit of the column to prevent enzymes from being carried out. The enzyme used is Novozymes 435 lipase and the enzyme activity is 10000 U/g. The enzyme application experiment was performed 40 times in the scheme of Example 1, and the enzyme still had a high efficiency. Lipase column A detected enzyme activity 7230 U/g, lipase column B detected enzyme activity 8243 U/g. The water-washing extraction tower is constructed by laboratory glass tower section and wire mesh packing, and the other steps of filtration and concentration are all commonly used instruments in the laboratory.
尽管上面已经示出和描述了本发明的实施例,可以理解的是,上述实施例是示例性的,不能理解为对本发明的限制,本领域的普通技术人员在不脱离本发明的原理和宗旨的情况下在本发明的范围内可以对上述实施例进行变化、修改、替换和变型。Although the embodiments of the present invention have been shown and described above, it can be understood that the above embodiments are exemplary and should not be construed as limiting the present invention. Those of ordinary skill in the art will not depart from the principle and purpose of the present invention. Under the circumstances, changes, modifications, substitutions and modifications can be made to the above-mentioned embodiments within the scope of the present invention.

Claims (44)

  1. 一种维生素D 3的提纯方法,其特征在于,包括如下步骤: A method for purifying vitamin D 3 , which is characterized in that it comprises the following steps:
    S1.以维生素D 3粗品为底物,在非水相溶剂中与弱有机酸或酸酐混合,通过脂肪酶柱A进行酯化反应,得到含维生素D 3酯的酯化液; S1. Use the crude vitamin D 3 as a substrate, mix it with a weak organic acid or anhydride in a non-aqueous solvent, and perform an esterification reaction through lipase column A to obtain an esterified liquid containing vitamin D 3 ester;
    S2.将所得含维生素D 3酯的酯化液用萃取剂进行萃取,残余酸进入水层,维生素D 3酯进入有机层,将有机层进行浓缩得到浓缩的维生素D 3酯; S2. Extract the obtained esterified liquid containing vitamin D 3 ester with an extractant, the residual acid enters the water layer, the vitamin D 3 ester enters the organic layer, and the organic layer is concentrated to obtain a concentrated vitamin D 3 ester;
    S3.将浓缩的维生素D 3酯加入结晶溶剂溶解后降温结晶,过滤、烘干得到维生素D 3酯结晶; S3. The concentrated vitamin D 3 ester is added to the crystallization solvent to dissolve it and then cooled and crystallized, filtered and dried to obtain vitamin D 3 ester crystals;
    S4.将所得的维生素D 3酯结晶用非水相溶剂溶解后,通过脂肪酶柱B进行皂化反应,得皂化液;将皂化液用水进行萃取,分离出的有机酸进入水层,有机层重回脂肪酶柱B再次皂化水解残存的维生素D 3酯,重复循环皂化-水解的步骤2~5次直至有机相中维生素D 3酯残存<1wt%后,停止循环; S4. After dissolving the obtained vitamin D 3 ester crystals in a non-aqueous solvent, the saponification reaction is carried out through the lipase column B to obtain a saponification liquid; the saponification liquid is extracted with water, and the separated organic acid enters the water layer, and the organic layer is heavy Return to the lipase column B to saponify and hydrolyze the remaining vitamin D 3 ester again, and repeat the cycle of saponification-hydrolysis step 2 to 5 times until the residual vitamin D 3 ester in the organic phase is less than 1wt%, then stop the circulation;
    S5.将有机层进行浓缩、结晶、烘干,得维生素D 3结晶精品。 S5. Concentrate, crystallize and dry the organic layer to obtain vitamin D 3 crystal products.
  2. 如权利要求1所述维生素D 3的提纯方法,其特征在于,S3步骤中结晶的母液经浓缩、皂化、热异构后得到饲料级维生素D 3 The method for purifying vitamin D 3 according to claim 1, wherein the mother liquor crystallized in step S3 is concentrated, saponified, and thermally isomerized to obtain feed-grade vitamin D 3 .
  3. 如权利要求1所述维生素D 3的提纯方法,其特征在于,S5步骤中结晶的母液经浓缩、热异构后作为S1步骤的底物利用。 The method for purifying vitamin D 3 according to claim 1, wherein the mother liquor crystallized in step S5 is used as the substrate of step S1 after being concentrated and thermally isomerized.
  4. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中的维生素D 3粗品的含量为1500-3500IU/g。 The method for purifying vitamin D 3 according to claim 1 , wherein the content of the crude vitamin D 3 in the step S1 is 1500-3500 IU/g.
  5. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述S1步骤中的底物与非水相溶剂的重量体积比为1g:(5~30)ml。 The method for purifying vitamin D 3 according to claim 1, wherein in the S1 step, the weight-volume ratio of the substrate and the non-aqueous solvent in the S1 step is 1 g: (5-30) ml.
  6. 如权利要求5所述维生素D 3的提纯方法,其特征在于,所述S1步骤中的底物与非水相溶剂的重量体积比为1g:8ml。 The method for purifying vitamin D 3 according to claim 5, wherein the weight-volume ratio of the substrate and the non-aqueous solvent in the step S1 is 1 g: 8 ml.
  7. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述S1步骤和S4步骤中,所述的非水相溶剂各自独立地为烷烃、卤代烃或芳香烃。 The method for purifying vitamin D 3 according to claim 1, wherein in the S1 step, in the S1 step and the S4 step, the non-aqueous solvent is each independently an alkane, a halogenated hydrocarbon or an aromatic hydrocarbon.
  8. 如权利要求7所述维生素D 3的提纯方法,其特征在于,所述烷烃选自正己烷、戊烷、庚烷、环己烷和石油醚中的至少一种。 8. The method for purifying vitamin D 3 according to claim 7, wherein the alkane is at least one selected from the group consisting of n-hexane, pentane, heptane, cyclohexane and petroleum ether.
  9. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,底物与弱有机酸的摩尔比为1:(1.0~10)。 The method for purifying vitamin D 3 according to claim 1, wherein in the S1 step, the molar ratio of the substrate to the weak organic acid is 1: (1.0-10).
  10. 如权利要求9所述维生素D 3的提纯方法,其特征在于,所述底物与弱有机酸的摩尔比为1:1.1。 9. The method for purifying vitamin D 3 according to claim 9, wherein the molar ratio of the substrate to the weak organic acid is 1:1.1.
  11. 如权利要求10所述维生素D 3的提纯方法,其特征在于,所述弱有机酸为丁酸、戊酸或月桂酸。 The method for purifying vitamin D 3 according to claim 10, wherein the weak organic acid is butyric acid, valeric acid or lauric acid.
  12. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述酸酐为正丁酸酐、丁二酸酐或戊酸酐。 The method for purifying vitamin D 3 according to claim 1, wherein in step S1, the acid anhydride is n-butyric anhydride, succinic anhydride or valeric anhydride.
  13. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述底物与酸酐的摩尔比为1:(0.5~5)。 The method for purifying vitamin D 3 according to claim 1, wherein in the S1 step, the molar ratio of the substrate to the acid anhydride is 1: (0.5-5).
  14. 如权利要求13所述维生素D 3的提纯方法,其特征在于,所述底物与酸酐的摩尔比为1:0.55。 The method for purifying vitamin D 3 according to claim 13, wherein the molar ratio of the substrate to the acid anhydride is 1:0.55.
  15. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述酯化反应的温度为20~50℃。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S1, the temperature of the esterification reaction is 20-50°C.
  16. 如权利要求15所述维生素D 3的提纯方法,其特征在于,所述酯化反应的温度为35℃。 The method for purifying vitamin D 3 according to claim 15, wherein the temperature of the esterification reaction is 35°C.
  17. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述通过脂肪酶柱A时物料在柱内的停留时间为0.5~5小时。 The method for purifying vitamin D 3 according to claim 1, characterized in that, in the step S1, the residence time of the material in the column when passing through the lipase column A is 0.5 to 5 hours.
  18. 如权利要求17所述维生素D 3的提纯方法,其特征在于,所述通过脂肪酶柱A时物料在柱内的停留时间为1小时。 The method for purifying vitamin D 3 according to claim 17, wherein the residence time of the material in the column when passing through the lipase column A is 1 hour.
  19. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S2步骤中,所述萃取剂为水或含水甲醇。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S2, the extractant is water or aqueous methanol.
  20. 如权利要求19所述维生素D 3的提纯方法,其特征在于,所述含水甲醇中甲醇的体积含量为0~98%。 The method for purifying vitamin D 3 according to claim 19, wherein the volume content of methanol in the aqueous methanol is 0-98%.
  21. 如权利要求20所述维生素D 3的提纯方法,其特征在于,所述含水甲醇中甲醇的体积含量为95%。 The method for purifying vitamin D 3 according to claim 20, wherein the volume content of methanol in the aqueous methanol is 95%.
  22. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S2步骤中,所述萃取剂与含维生素D 3酯的酯化液的进料体积比为(0.2~3):1。 The method for purifying vitamin D 3 according to claim 1, characterized in that, in the step S2, the feed volume ratio of the extractant to the esterified liquid containing the vitamin D 3 ester is (0.2~3):1 .
  23. 如权利要求22所述维生素D 3的提纯方法,其特征在于,所述萃取剂与含维生素D 3酯的酯化液的进料体积比为0.8:1。 The method for purifying vitamin D 3 according to claim 22, wherein the feed volume ratio of the extractant to the esterified liquid containing the vitamin D 3 ester is 0.8:1.
  24. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S2步骤和S4步骤中的萃取操作在萃取塔中进行。 The method for purifying vitamin D 3 according to claim 1, wherein the extraction operations in the S2 step and the S4 step are performed in an extraction tower.
  25. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S3步骤中,所述结晶溶剂为酮类或醇类溶剂。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S3, the crystallization solvent is a ketone or alcohol solvent.
  26. 如权利要求25所述维生素D 3的提纯方法,其特征在于,所述结晶溶剂为丙酮。 The method for purifying vitamin D 3 according to claim 25, wherein the crystallization solvent is acetone.
  27. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S3步骤中,所述结晶的温度为-5~-30℃。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S3, the temperature of the crystallization is -5 to -30°C.
  28. 如权利要求27所述维生素D 3的提纯方法,其特征在于,所述结晶的温度为-20℃。 The method for purifying vitamin D 3 according to claim 27, wherein the temperature of the crystallization is -20°C.
  29. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S3步骤中,浓缩的维生素D 3酯与结晶溶剂的比例为1g:(0.7~5)ml。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S3, the ratio of the concentrated vitamin D 3 ester to the crystallization solvent is 1 g: (0.7-5) ml.
  30. 如权利要求29所述维生素D 3的提纯方法,其特征在于,所述浓缩的维生素D 3酯与结晶溶剂的比例为1g:1ml。 The method for purifying vitamin D 3 according to claim 29, wherein the ratio of the concentrated vitamin D 3 ester to the crystallization solvent is 1 g:1 ml.
  31. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S4步骤中,所述维生素D 3酯结晶与非水相溶剂的质量体积比例为1g:(2~30)ml。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S4, the mass-volume ratio of the vitamin D 3 ester crystal and the non-aqueous solvent is 1 g: (2-30) ml.
  32. 如权利要求31所述维生素D 3的提纯方法,其特征在于,所述维生素D 3酯结晶与非水相溶剂的质量体积比例为1g:5ml。 The method for purifying vitamin D 3 according to claim 31 , wherein the mass volume ratio of the vitamin D 3 ester crystals and the non-aqueous solvent is 1 g: 5 ml.
  33. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S4步骤中,所述皂化反应的温度为20~50℃。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S4, the temperature of the saponification reaction is 20-50°C.
  34. 如权利要求33所述维生素D 3的提纯方法,其特征在于,所述皂化反应的温度为35℃。 The method for purifying vitamin D 3 according to claim 33, wherein the temperature of the saponification reaction is 35°C.
  35. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S5步骤中,所述结晶的溶剂为甲酸甲酯或者乙酸乙酯。 The method for purifying vitamin D 3 according to claim 1, wherein in step S5, the solvent for crystallization is methyl formate or ethyl acetate.
  36. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S5步骤中,所述结晶的温度为0~10℃,保温3小时以上。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S5, the temperature of the crystallization is 0-10°C, and the temperature is kept for more than 3 hours.
  37. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S5步骤中,所述有机层进行浓缩所得的浓缩物与结晶溶剂的质量体积比例为1g:(4~20)ml。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S5, the mass-volume ratio of the concentrate obtained by concentrating the organic layer to the crystallization solvent is 1 g: (4-20) ml.
  38. 如权利要求37所述维生素D 3的提纯方法,其特征在于,所述有机层进行浓缩所得的浓缩物与结晶溶剂的质量体积比例为1g:6ml。 The method for purifying vitamin D 3 according to claim 37, wherein the mass-volume ratio of the concentrate obtained by concentrating the organic layer to the crystallization solvent is 1 g: 6 ml.
  39. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤和S4步骤中,所述脂肪酶柱A和脂肪酶柱B中的脂肪酶为经固定化处理的南极假丝酵母脂肪酶B,或采用CN105462952A中公开的固定化方法处理的南极假丝脂肪酶B。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S1 and the step S4, the lipase in the lipase column A and the lipase column B is immobilized Candida antarctica Yeast lipase B, or Candida Antarctica lipase B treated with the immobilization method disclosed in CN105462952A.
  40. 如权利要求39所述维生素D 3的提纯方法,其特征在于,所述脂肪酶柱A和脂肪酶柱B中的脂肪酶为各自独立地为诺维信435固定化脂肪酶。 The method for purifying vitamin D 3 according to claim 39, wherein the lipase in the lipase column A and the lipase column B is independently Novozymes 435 immobilized lipase.
  41. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S1步骤中,所述底物与脂肪酶柱A中的脂肪酶的质量比为1:(0.2~30)。 The method for purifying vitamin D 3 according to claim 1, wherein in the step S1, the mass ratio of the substrate to the lipase in the lipase column A is 1:(0.2-30).
  42. 如权利要求41所述维生素D 3的提纯方法,其特征在于,所述底物与脂肪酶柱A中的脂肪酶的质量比为1:(0.5-2)。 The method for purifying vitamin D 3 according to claim 41, wherein the mass ratio of the substrate to the lipase in the lipase column A is 1: (0.5-2).
  43. 如权利要求1所述维生素D 3的提纯方法,其特征在于,所述S4步骤中,所述维生素D 3酯结晶与脂肪酶柱B中的脂肪酶的质量比为1:(0.2~30)。 The method for purifying vitamin D 3 according to claim 1, wherein in the S4 step, the mass ratio of the vitamin D 3 ester crystals and the lipase in the lipase column B is 1:(0.2-30) .
  44. 如权利要求43所述维生素D 3的提纯方法,其特征在于,所述维生素D 3酯结晶与脂肪酶柱B中的脂肪酶的质量比为1:(0.5-2)。 The method for purifying vitamin D 3 according to claim 43 , wherein the mass ratio of the vitamin D 3 ester crystal to the lipase in the lipase column B is 1: (0.5-2).
PCT/CN2020/093960 2019-08-30 2020-06-02 Method for purifying vitamin d3 WO2021036384A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910812709.4A CN110527700B (en) 2019-08-30 2019-08-30 Vitamin D3Purification method of (2)
CN201910812709.4 2019-08-30

Publications (1)

Publication Number Publication Date
WO2021036384A1 true WO2021036384A1 (en) 2021-03-04

Family

ID=68665400

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/093960 WO2021036384A1 (en) 2019-08-30 2020-06-02 Method for purifying vitamin d3

Country Status (2)

Country Link
CN (1) CN110527700B (en)
WO (1) WO2021036384A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110527700B (en) * 2019-08-30 2021-07-16 厦门金达威维生素有限公司 Vitamin D3Purification method of (2)
CN112479960B (en) * 2020-12-12 2023-02-21 弘健制药(上海)有限公司 Vitamin D 3 Purification method of (2)
CN114369047A (en) * 2022-01-27 2022-04-19 重庆迈德凯医药有限公司 Method for crystallizing vitamin D3

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157678A (en) * 1959-08-04 1964-11-17 Philips Corp Method of producing a crystalline ester of vitamin d3 and crystalline vitamin d3 which may be obtained therefrom
CN1223639A (en) * 1996-07-01 1999-07-21 中外制药株式会社 Crystals of vitamin D derivatives and process for the preparation thereof
CN1240209A (en) * 1998-06-23 2000-01-05 弗·哈夫曼-拉罗切有限公司 Separation process for vitamin D3
CN110527700A (en) * 2019-08-30 2019-12-03 厦门金达威维生素有限公司 A kind of vitamin D3Method of purification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1481061A (en) * 1964-12-19 1967-05-19 Starogardzkie Zakl Farma Process for extracting cholecalciferol from a mixture obtained by irradiation of 7-dehydro cholesterol
CN1167677C (en) * 2000-10-18 2004-09-22 浙江新和成股份有限公司 Technological process of purifying vitamin D3
CN100347156C (en) * 2005-05-31 2007-11-07 台州市海盛化工有限公司 Vitamin D separating, purifying and crystallizing method
CN102276510A (en) * 2011-05-30 2011-12-14 何德海 Technological method for preparing vitamin D3
CN106478479B (en) * 2016-08-31 2018-08-07 四川省玉鑫药业有限公司 A kind of vitamin D3Production technology

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157678A (en) * 1959-08-04 1964-11-17 Philips Corp Method of producing a crystalline ester of vitamin d3 and crystalline vitamin d3 which may be obtained therefrom
CN1223639A (en) * 1996-07-01 1999-07-21 中外制药株式会社 Crystals of vitamin D derivatives and process for the preparation thereof
CN1240209A (en) * 1998-06-23 2000-01-05 弗·哈夫曼-拉罗切有限公司 Separation process for vitamin D3
CN110527700A (en) * 2019-08-30 2019-12-03 厦门金达威维生素有限公司 A kind of vitamin D3Method of purification

Also Published As

Publication number Publication date
CN110527700B (en) 2021-07-16
CN110527700A (en) 2019-12-03

Similar Documents

Publication Publication Date Title
WO2021036384A1 (en) Method for purifying vitamin d3
CN109761867B (en) Vitamin D production by using lanolin as raw material3Is a new method for industrialization
CN111094312B (en) Preparation method of sucrose ester
CN111499529B (en) Synthetic method of ultraviolet absorber UVA Plus
JP2008530170A (en) Continuous process for the production of cyclohexyl (meth) acrylate
CN101774997B (en) Method for completely and continuously extracting natural vitamin E and phytosterol
WO2022233040A1 (en) Method for purifying sucralose-6-ethyl ester
CN102203047B (en) Process for production of optically active organic carboxylic acid
JP7186313B2 (en) Production of malic acid
CN114621107A (en) Method for recycling product from dapoxetine hydrochloride mother liquor
CN113087630A (en) Method for recycling and applying perindopril intermediate resolving agent (R) - (+) -alpha-phenylethylamine
CN108299538B (en) Method for removing isoursodesoxycholic acid in duck bile
CN113527064A (en) Preparation method of phloroglucinol
CN112940054A (en) Preparation method of sucrose ester with high monoester content
CN111620775A (en) Method for preparing cycloartenyl ferulate by selectively hydrolyzing oryzanol
CN114380726B (en) Method for preparing vitamin D3 by recovering mother solution for separating and purifying vitamin D3 crude product
CN112694397B (en) Method for purifying 2, 6-naphthalenedicarboxylic acid
CN108329309A (en) A kind of succinic acid Solifenacin bulk pharmaceutical chemicals synthesis technology
CN104591996B (en) A kind of process for purification of organic acid
CN112409179B (en) Purification method of menthyl lactate
CN108250255A (en) A kind of method for improving trichloro-cane-6-ethyl ester crystallization yield
CN106496174B (en) A kind of extraction and purification process of Lovastatin
WO2023000516A1 (en) Purification method for paeoniflorin-6-o&#39;-benzene sulfonate
CN117024261A (en) Extraction method of coenzyme Q10
CN112939809A (en) Preparation method of 1-cyano-3-methyl diethyl butylmalonate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20856786

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20856786

Country of ref document: EP

Kind code of ref document: A1